| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF182 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | MPO | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | TBK1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | SPATS2L | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | INTS9 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CCNO | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | RNF25 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | OSBPL6 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | ADORA1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | TSPAN1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |
